Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Follow-Up Questions
What is Danaher Corp (DHR)'s P/E Ratio?
The P/E ratio of Danaher Corp is 37.9513
Who is the CEO of Danaher Corp?
Mr. Rainer Blair is the President of Danaher Corp, joining the firm since 2014.
What is the price performance of DHR stock?
The current price of DHR is $212.79, it has decreased 0.59% in the last trading day.
What are the primary business themes or industries for Danaher Corp?
Danaher Corp belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Danaher Corp market cap?
Danaher Corp's current market cap is $152.3B
Is Danaher Corp a buy, sell, or hold?
According to wall street analysts, 23 analysts have made analyst ratings for Danaher Corp, including 12 strong buy, 15 buy, 3 hold, 0 sell, and 12 strong sell
